This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Macritchie, K. A. N. Articles by Hunt, N. J. Search for Related Content PubMed PubMed Citation Articles by Macritchie, K. A. N. Articles by Hunt, N. J. Social Bookmarking                         What's this?

Does ‘rebound mania’ occur after stopping carbamazepine? A pilot study

George MacKenzie House, Fulbourn Hospital, Fulbourn, Cambridge, UK

Neil J. Hunt

George MacKenzie House, Fulbourn Hospital, Fulbourn, Cambridge, CB1 5EF UK; nh212{at}cam.ac.uk

Withdrawal of lithium prophylaxis in patients with bipolar affective disorder has been shown to precipitate ‘rebound mania’, an effect which may negate its benefits in the poorly compliant. No studies have looked for similar effects on withdrawal of carbamazepine, an alternative and adjunctive prophylactic treatment. This retrospective study examined the effects of withdrawal of carbamazepine prophylaxis in patients with bipolar disorder. A systematic search for patients with bipolar disorder who stopped carbamazepine therapy whilst in remission was conducted, followed by case note review and interview. In a case series of six patients who stopped carbamazepine, four remained well for at least 3 months, one developed an episode of moderate depression and one remained well before resuming treatment after 1 month. None required admission or suffered a manic episode in the 3 months following cessation. This study does not support the existence of a carbamazepine ‘rebounD’ effect. It raises the possibility that recurrence after stopping carbamazepine may be less severe than the ‘rebound mania’ seen on lithium withdrawal. If this is the case, it may be a better choice of mood stabilizer in the poorly compliant. To date, there is insufficient evidence on which to base this choice. There is a need to examine this issue further through larger prospective and experimental studies on the effects of anticonvulsant withdrawal.

Key Words: bipolar disorder • carbamazepine • mania • prophylaxis • rebound

Journal of Psychopharmacology, Vol. 14, No. 3, 266-268 (2000)
DOI: 10.1177/026988110001400312


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Franks, K. Macritchie, T Mahmood, and A. Young Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study J Psychopharmacol, June 1, 2008; 22(4): 452 - 456. [Abstract] [PDF]

				G. E. JESS, D. J. SMITH, C. MacKENZIE, and C. CRAWFORD Carbamazepine and Rebound Mania Am J Psychiatry, November 1, 2004; 161(11): 2132 - 2133. [Full Text] [PDF]

				I N. Ferrier Developments in mood stabilisers: Depression and public health Br. Med. Bull., March 1, 2001; 57(1): 179 - 192. [Abstract] [Full Text] [PDF]